HSA — authorised 1 September 2022
- Marketing authorisation holder: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
- Status: likely_approved
🇸🇬 Spevigo in Singapore
HSA authorised Spevigo on 1 September 2022
Marketing authorisation
Spevigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Singapore
Frequently asked questions
Is Spevigo approved in Singapore?
Yes. HSA authorised it on 1 September 2022.
Who is the marketing authorisation holder for Spevigo in Singapore?
BOEHRINGER INGELHEIM PHARMACEUTICALS INC holds the Singaporean marketing authorisation.